VCYT

Veracyte (VCYT)

Veracyte Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VCYT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/31	05 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/05/29	05 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VCYT	Veracyte Inc
2024/05/23	05 : 05	Business Wire	Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer	NASDAQ:VCYT	Veracyte Inc
2024/05/16	06 : 04	Business Wire	Veracyte to Participate in Upcoming Investor Conferences	NASDAQ:VCYT	Veracyte Inc
2024/05/09	06 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VCYT	Veracyte Inc
2024/05/08	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VCYT	Veracyte Inc
2024/05/08	05 : 05	Business Wire	Veracyte Announces First Quarter 2024 Financial Results	NASDAQ:VCYT	Veracyte Inc
2024/05/07	05 : 05	Business Wire	14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding	NASDAQ:VCYT	Veracyte Inc
2024/04/23	06 : 00	Business Wire	Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024	NASDAQ:VCYT	Veracyte Inc
2024/04/22	21 : 30	Business Wire	New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance	NASDAQ:VCYT	Veracyte Inc
2024/04/16	21 : 30	Business Wire	Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024	NASDAQ:VCYT	Veracyte Inc
2024/03/09	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/09	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/09	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/09	06 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/09	06 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/09	06 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/06	07 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/06	07 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/06	07 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/06	07 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/06	07 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VCYT	Veracyte Inc
2024/03/01	07 : 27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VCYT	Veracyte Inc
2024/03/01	07 : 22	Edgar (US Regulatory)	Form 424B7 - Prospectus [Rule 424(b)(7)]	NASDAQ:VCYT	Veracyte Inc
2024/03/01	07 : 20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VCYT	Veracyte Inc
2024/03/01	06 : 40	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:VCYT	Veracyte Inc
2024/02/29	22 : 06	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:VCYT	Veracyte Inc
2024/02/28	07 : 55	Business Wire	Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines	NASDAQ:VCYT	Veracyte Inc
2024/02/23	06 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VCYT	Veracyte Inc
2024/02/23	06 : 05	Business Wire	Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results	NASDAQ:VCYT	Veracyte Inc